Division of Pre-Clinical Innovation

E93882

The Division of Pre-Clinical Innovation is a research branch of the National Center for Advancing Translational Sciences focused on developing and applying innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies.

AI illustration

How this image was made

AI-generated illustration of Division of Pre-Clinical Innovation

This AI-generated illustration was produced by black-forest-labs/FLUX.2-dev (1024x1024) from a prompt written by openai/gpt-oss-120b from the entity's label + description.

Prompt

Generate an image of the Division of Pre-Clinical Innovation (The Division of Pre-Clinical Innovation is a research branch of the National Center for Advancing Translational Sciences focused on developing and applying innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies.)

All labels observed (1)

Label Occurrences
Division of Pre-Clinical Innovation canonical 2

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf organizational unit ⓘ
research division ⓘ
abbreviation DPI ⓘ
activity conducts collaborative preclinical research projects ⓘ
develops novel screening technologies ⓘ
develops predictive preclinical models ⓘ
optimizes lead compounds for therapeutic use ⓘ
supports translational projects across disease areas ⓘ
country United States ⓘ
employer National Center for Advancing Translational Sciences staff ⓘ
employs research staff ⓘ
scientists ⓘ
technical staff ⓘ
field assay development ⓘ
biomarker discovery ⓘ
chemical biology ⓘ
drug discovery ⓘ
high-throughput screening ⓘ
preclinical research ⓘ
preclinical therapeutics ⓘ
rare diseases research ⓘ
repurposing of existing drugs ⓘ
therapeutic development ⓘ
toxicology ⓘ
translational science ⓘ
focus early-stage therapeutic development ⓘ
innovative preclinical methods ⓘ
partnerships with academic investigators ⓘ
partnerships with industry ⓘ
partnerships with patient advocacy groups ⓘ
platform technologies for drug discovery ⓘ
translation of basic scientific discoveries into potential therapies ⓘ
fundingSource National Institutes of Health budget ⓘ
U.S. federal government ⓘ
goal to improve the success rate of candidate therapeutics entering clinical trials ⓘ
to reduce the time and cost of therapeutic development ⓘ
jurisdiction United States federal government ⓘ
languageOfWork English ⓘ
locatedIn Maryland ⓘ
Rockville, Maryland ⓘ
mission to develop and apply innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies ⓘ
parentOrganization National Center for Advancing Translational Sciences ⓘ
National Institutes of Health ⓘ
partOf NCATS ⓘ
National Center for Advancing Translational Sciences ⓘ
National Institutes of Health ⓘ
sector biomedical research ⓘ
website https://ncats.nih.gov/about/organization/dpi ⓘ

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

National Center for Advancing Translational Sciences → hasPart → Division of Pre-Clinical Innovation ⓘ
DPI → standsFor → Division of Pre-Clinical Innovation ⓘ